( OTC-PINK:RHHBY,OTC-QX:RHHBY )

News from Roche Diagnostics A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

Jan 05, 2017, 20:31 ET Roche gains FDA Clearance for 18-Minute Anti-Müllerian Hormone Test to Assess Ovarian Reserve

Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that it received clearance from U.S. Food and Drug Administration (FDA) via Direct de novo...


Oct 25, 2016, 15:30 ET Mayor, Roche chairman lead Indianapolis site dedication

Today, Indianapolis Mayor Joe Hogsett joined Chairman of the Roche Group Christoph Franz, global and local Roche leaders, and employees to lead a...


Oct 24, 2016, 07:00 ET LabCorp is first US laboratory to offer molecular testing with new fully automated cobas 8800 system from Roche

Roche (SIX: RO, ROG; OTCQX: RHHBY) and Laboratory Corporation of America® Holdings (LabCorp®) (NYSE:LH) announced today that the LabCorp Center for...


Aug 02, 2016, 07:00 ET Roche introduces virtual reality theater at AACC 2016 Clinical Lab Expo to give lab professionals firsthand glimpse of connected lab of the future

Roche (SIX: RO, ROG; OTCQX: RHHBY) launched its presence at the American Association for Clinical Chemistry (AACC) 2016 Clinical Lab Expo today by...


Jul 15, 2016, 12:52 ET CoaguChek® PT/ INR devices for use at the point of care and for patient self-testing remain a safe and effective option for patients on anticoagulation therapy

Point-of-care and patient self-testing (PST) are growing standards of care for patients requiring regular PT/INR tests for warfarin therapy. ...


Mar 21, 2016, 07:42 ET FDA approves expanded use of Roche hepatitis C virus RNA test as aid in diagnosis

Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that it has received approval from the U.S. Food and Drug Administration (FDA) for...


Feb 01, 2016, 11:00 ET Updated cervical cancer screening guidelines from leading ob-gyn society support expanded use of cobas HPV Test for primary screening

 Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that recently updated cervical cancer screening guidelines from the American College of...


Dec 17, 2015, 07:00 ET Roche Submits Anti-Mullerian Hormone Assay for FDA Approval

Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that it has filed a direct de novo application to the U.S. Food and Drug Administration (FDA)...


Aug 31, 2015, 15:18 ET Indiana Lt. Gov. Sue Ellspermann and State Sen. Brandt Hershman Kick Off New Life Sciences Policy Series

The Indiana Medical Device Manufacturers Council and the Indiana Health Industry Forum today introduced The MedTech/Life Sciences Policy Forum to...


Jan 08, 2015, 10:30 ET ATHENA data publication reinforces new interim guidance from medical societies on use of HPV as first-line test in cervical cancer screening

Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that three-year end-of-study data from the ATHENA trial published today in Gynecologic Oncology...


Dec 10, 2014, 09:00 ET Roche Diagnostics purchases tissue dissection technology from AvanSci Bio

Roche Diagnostics (SIX: RO, ROG; OTCQX: RHHBY) has signed a definitive Asset Purchase Agreement with AvanSci Bio for all products associated with...


Jul 29, 2014, 10:44 ET Roche focuses on partnering with customers to redefine the value of the laboratory at the AACC 2014 Clinical Lab Expo

 Roche (SIX: RO, ROG; OTCQX: RHHBY) launched its presence at the American Association for Clinical Chemistry (AACC) 2014 Clinical Lab Expo...


Jun 10, 2014, 16:00 ET Health Canada Approves Roche's HPV Test for First-Line Primary Screening of Cervical Cancer and Roche Launches New Cytology Test to Provide the Most Comprehensive Portfolio for Cervical Cancer Screening

LAVAL, QC, June 10, 2014 /CNW Telbec/ - Roche announced that Health Canada approved the cobas® 4800 HPV (Human Papillomavirus) Test for...


May 20, 2014, 16:30 ET Roche Diagnostics recognizes Pathology, Inc as Roche Molecular Center of Excellence

Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today the establishment of a strategic alliance with Pathology, Inc. in Torrance, Calif.,...


Jul 30, 2013, 12:00 ET Roche unveils intelligent automation management solution at 2013 Clinical Lab Expo

Roche (SIX: RO, ROG; OTCQX: RHHBY) announced plans today at the AACC 2013 Clinical Lab Expo for the U.S. introduction of the cobas 8100 automated...


Jul 01, 2013, 11:00 ET Roche Diagnostics ranked #1 in overall service performance in independent survey of U.S. clinical laboratories

Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that its U.S. Diagnostics unit was ranked number one in overall service performance by...


Jun 26, 2013, 11:00 ET FDA approves new streamlined workflow option for Roche's cobas HPV Test

 Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the U.S. Food and Drug Administration (FDA) has approved a new,...


Jan 17, 2013, 12:00 ET Roche Diagnostics Named to FORTUNE magazine's 2013 list of "100 Best Companies to Work For"

Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that Roche Diagnostics Corporation has been selected to FORTUNE magazine's annual list of the...


Dec 19, 2012, 08:07 ET Roche's Rapid Mycoplasma Detection Test MycoTOOL Receives FDA Acceptance for Release Testing of Biopharmaceutical Roche Product

First commercially available mycoplasma PCR test accepted by FDA reduces time for detection from one month to one day Today Roche announced that...


Nov 14, 2012, 10:30 ET Roche Diagnostics Breaks Ground on New Learning and Development Center

 Mayor Greg Ballard today joined Roche Diagnostics President and CEO Jack Phillips as well as other Roche executives and community leaders to...


Nov 12, 2012, 11:00 ET Roche launches additional test for improved management of epithelial ovarian cancer patients

Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today the U.S. market availability of the Elecsys HE4 assay, an FDA approved test used...


Oct 03, 2012, 11:00 ET Roche's new dual-target HIV-1 viral load test now available in US

Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today the U.S. availability of a new HIV-1 viral load test based on the company's proprietary...


Oct 01, 2012, 11:00 ET FDA grants CLIA-waived status to CoaguChek XS Plus system for PT/INR testing at the point of care

Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the U.S. Food and Drug Administration (FDA) has granted CLIA-waived status to the...


Sep 17, 2012, 11:00 ET Roche cytomegalovirus viral load test now available in US

Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today the commercial availability of a new test to assess a patient's viral load of cytomegalovirus...


Sep 04, 2012, 11:00 ET Roche receives FDA clearance for herpes simplex virus type 1 and 2 tests

 Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that it has received clearance from the U.S. Food and Drug Administration (FDA) for its IgG...